{"id":"W4292565458","doi":"10.1200/jco.22.00294","title":"Ripretinib Versus Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Treatment With Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III Trial","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Deciphera Pharmaceuticals; U.S. Department of Veterans Affairs","keywords":"Medicine; Sunitinib; GiST; Internal medicine; Hazard ratio; Imatinib; Clinical endpoint; Gastroenterology; Tyrosine-kinase inhibitor; Imatinib mesylate; Oncology; Progression-free survival; Surgery; Randomized controlled trial; Confidence interval; Cancer; Stromal cell; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003746273,0.0004101582,0.003510076,0.0003073308,0.0001296369,0.00004117048,0.0003584299,0.0000501067,0.0009233601],"category_scores_gemma":[0.003158477,0.0002386059,0.0003719382,0.0003430785,0.0005255138,0.000224537,0.0002260804,0.001574027,0.000009207019],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009369637,"about_ca_system_score_gemma":0.003964107,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001018372,"about_ca_topic_score_gemma":0.0001084688,"domain_scores_codex":[0.9926674,0.001994206,0.002988629,0.0004800775,0.001147152,0.0007225368],"domain_scores_gemma":[0.9910243,0.004573721,0.002471283,0.0003599444,0.0006631864,0.0009076195],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8895627,0.04409621,0.03058399,0.00001340092,0.0005529518,0.01653389,0.00006012868,0.00002450195,0.000005371237,0.00002027307,0.00008077673,0.01846577],"study_design_scores_gemma":[0.590372,0.4009492,0.005459795,0.0001923206,0.0004869894,0.001536551,0.000200329,0.00007945462,0.000004714345,0.00001536578,0.0005900983,0.0001131206],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929849,0.00006972727,0.00007471799,0.00116795,0.0003394293,0.004114262,0.00005799128,0.00001393215,0.001177101],"genre_scores_gemma":[0.9712725,0.00001610334,0.02726746,0.0002589613,0.0003015344,0.000648413,0.00005059726,0.00004595846,0.0001384688],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.356853,"threshold_uncertainty_score":0.9999899,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1062182956752445,"score_gpt":0.4614978297003581,"score_spread":0.3552795340251135,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}